Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at Piper Sandler Diabetes Day (Virtual) Transcript

Jun 01, 2020 / 02:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Piper Sandler Virtual Diabetes Day with Insulet Corporation. (Operator Instructions)

It is now my pleasure to turn the call over to Matt O'Brien to begin. Please go ahead, sir.

Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

All right. Thank you, Maria. Good morning, everybody. Thanks so much for joining us today on our Virtual Diabetes Investor Day. This is Matt O'Brien from Piper Sandler's MedTech research team. We are extremely pleased to have Insulet leading us off here today. From the company is Wayde McMillan, the Executive Vice President, CFO and Treasurer; Bret Christensen, Executive Vice President and Chief Commercial Officer; and then Deb Gordon, Vice President of IR. This is a webinar, so we cannot get questions telephonically from the audience. (Operator Instructions)

With that preamble out of the way, let's go ahead and get started. Wayde, Bret and Deb, thank you so much for joining us this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot